<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Thiboutot, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andrea L Zaenglein, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert P Dellavalle, MD, PhD, MSPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Moise L Levy, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Cindy Owen, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Abena O Ofori, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 29, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Acne vulgaris is a common cutaneous disorder characterized by chronic or recurrent development of papules, pustules, or nodules on the face, neck, trunk, or proximal upper extremities  (<a class="graphic graphic_picture graphicRef98492 graphicRef62816 graphicRef80536 graphicRef129596 graphicRef129597 graphicRef117250 graphicRef70809 graphicRef98493 graphicRef59878 graphicRef115821" href="/z/d/graphic/98492.html" rel="external">picture 1A-J</a>). The pathogenesis of acne vulgaris involves the interaction of multiple factors that result in the formation of comedones and the development of inflammation.</p><p>Acne vulgaris is most frequent among adolescents and young adults but is not limited to these ages. The severity of skin involvement varies from minimal involvement to disfiguring and highly inflammatory presentations. Hyperpigmentation, scarring, and negative psychosocial effects are common complications.</p><p>The pathogenesis, clinical manifestations, and diagnosis of acne vulgaris will be reviewed here. Acne in children younger than adolescents is reviewed in greater detail separately. The treatment of acne vulgaris is also discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/131570.html" rel="external">"Acne in infants, young children, and preadolescents"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/42.html" rel="external">"Acne vulgaris: Overview of management"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/129467.html" rel="external">"Acne vulgaris: Management of moderate to severe acne in adolescents and adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/38.html" rel="external">"Oral isotretinoin therapy for acne vulgaris"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/37.html" rel="external">"Light-based, adjunctive, and other therapies for acne vulgaris"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/90260.html" rel="external">"Management of acne scars"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Acne vulgaris is common and occurs most frequently in adolescents and young adults. Estimates of the prevalence of acne vulgaris in adolescents range from 35 to over 90 percent [<a href="#rid1">1-3</a>]. </p><p>Acne often begins in the preadolescent period (ages 7 to 12 years) and resolves in the third decade, but may persist into adulthood or develop de novo in adulthood. Adolescent acne exhibits a male predominance; in contrast, postadolescent acne predominantly affects women [<a href="#rid4">4</a>]. (See  <a class="medical medical_review" href="/z/d/html/13615.html" rel="external">"Postadolescent acne in women"</a>.)</p><p>The prevalence of acne decreases with increasing age. A survey of over 1000 adults in the United States found the following rates of self-reported acne in males and females [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>20 to 29 years – 43 and 51 percent, respectively</p><p class="bulletIndent1"><span class="glyph">●</span>30 to 39 years – 20 and 35 percent, respectively</p><p class="bulletIndent1"><span class="glyph">●</span>40 to 49 years – 12 and 26 percent, respectively</p><p class="bulletIndent1"><span class="glyph">●</span>Ages 50 and older – 7 and 15 percent, respectively</p><p></p><p>Of note, studies using a clinical examination typically find a lower prevalence than survey studies that document self-reported acne.</p><p>Infantile acne, a variant of acne vulgaris, may begin in infancy. Mid-childhood acne (acne that develops in children ages one to six years) is uncommon and may be an indicator of an underlying condition warranting further evaluation. (See  <a class="medical medical_review" href="/z/d/html/131570.html" rel="external">"Acne in infants, young children, and preadolescents", section on 'Classification'</a> and  <a class="medical medical_review" href="/z/d/html/131570.html" rel="external">"Acne in infants, young children, and preadolescents", section on 'Clinical manifestations'</a>.)</p><p class="headingAnchor" id="H3"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Acne vulgaris is an inflammatory disorder of the pilosebaceous unit, which is comprised of the hair follicle and sebaceous gland. The pathogenesis of acne involves a complex interplay of host factors, such as androgen-mediated stimulation of sebaceous glands, dysbiosis within the microbiome of the pilosebaceous follicle, and innate and cellular immune responses, and may be influenced by factors such as genetics and, possibly, diet [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H4"><span class="h2">Lesion development</span><span class="headingEndMark"> — </span>The microcomedo (a small, hyperkeratotic plug composed of corneocytes in the lower portion of the follicular infundibulum; plural "microcomedones") is considered the precursor for the clinical lesions of acne vulgaris, which include closed comedones (often colloquially called "whiteheads"), open comedones (often colloquially called "blackheads"), and inflammatory papules, pustules, and nodules. The process by which microcomedones develop and evolve into other acne lesions remains to be elucidated but may involve interaction of four main pathogenic factors:</p><p class="bulletIndent1"><span class="glyph">●</span>Follicular hyperkeratinization</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased sebum production by sebaceous glands</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>C<em>utibacterium acnes </em>(<em>C. acnes</em>, formerly <em>Propionibacterium acnes</em>), an anaerobic diphtheroid that is a normal component of skin flora</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inflammation</p><p></p><p>The temporal sequence of events leading to formation of acne lesions is unknown. The following events have been proposed  (<a class="graphic graphic_figure graphicRef57892" href="/z/d/graphic/57892.html" rel="external">figure 1</a>): </p><p class="bulletIndent1"><span class="glyph">●</span>Accumulation of sebum and keratinous material converts a microcomedo into a closed comedo  (<a class="graphic graphic_picture graphicRef62816" href="/z/d/graphic/62816.html" rel="external">picture 1B</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The follicular orifice is opened with continued distension, forming an open comedo  (<a class="graphic graphic_picture graphicRef80536" href="/z/d/graphic/80536.html" rel="external">picture 1C</a>). Densely packed keratinocytes, oxidized lipids, and melanin contribute to the dark color of the open comedo.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Immune responses to <em>C. acnes</em> contribute to the development of inflammatory papules and pustules. Follicular rupture releases bacteria, proinflammatory lipids, and keratin into the surrounding dermis, leading to exacerbation of inflammation and/or nodule formation  (<a class="graphic graphic_picture graphicRef68412 graphicRef70809" href="/z/d/graphic/68412.html" rel="external">picture 1G, 1K</a>).</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Sebaceous glands and the role of androgens</span><span class="headingEndMark"> — </span>Androgens contribute to the development of acne by stimulating the growth and secretory function of sebaceous glands, leading to increased sebum production. Increased sebum production is thought to provide a growth medium for <em>C. acnes</em>. <em>C. acnes</em> utilizes triglycerides in sebum as a nutrient source by hydrolyzing them into free fatty acids and glycerol. The anaerobic, lipid-rich environment in microcomedos allows these bacteria to thrive.</p><p>Most circulating androgens are produced by the adrenal gland and the gonads  (<a class="graphic graphic_figure graphicRef71558" href="/z/d/graphic/71558.html" rel="external">figure 2</a>). Androgen production also occurs within the sebaceous glands, which convert dehydroepiandrosterone sulfate (DHEAS), an adrenal androgen precursor, to testosterone via the action of several enzymes  (<a class="graphic graphic_table graphicRef68437" href="/z/d/graphic/68437.html" rel="external">table 1</a>). Testosterone is subsequently converted to 5-alpha-dihydrotestosterone (DHT) via the action of type I 5-alpha reductase in the sebaceous gland.</p><p>The effects of androgens are mediated through androgen receptors. Androgen receptors that bind DHT and testosterone are present in the sebaceous glands and the outer root sheath keratinocytes of the follicular epithelium. DHT has greater affinity for androgen receptors than testosterone. </p><p>Clinical observations support the importance of androgens for the development of acne. Although the majority of patients with acne have normal androgen levels, androgen excess due to conditions such as polycystic ovarian syndrome, congenital adrenal hyperplasia, or adrenal or ovarian tumors can cause acne. In addition, acne typically does not develop prior to adrenarche (the prepubertal period in which levels of DHEAS rise), with the exception of infantile acne, a condition seen in infants that results from excess androgen production by immature adrenal glands or gonads. Moreover, men with androgen insensitivity do not produce sebum and do not develop acne [<a href="#rid6">6</a>]. (See  <a class="medical medical_review" href="/z/d/html/5852.html" rel="external">"Definition, clinical features, and differential diagnosis of polycystic ovary syndrome in adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/7430.html" rel="external">"Epidemiology, phenotype, and genetics of the polycystic ovary syndrome in adults"</a> and  <a class="medical medical_review" href="/z/d/html/147.html" rel="external">"Diagnosis and treatment of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency"</a> and  <a class="medical medical_review" href="/z/d/html/123.html" rel="external">"Adrenal hyperandrogenism"</a> and <a class="local">'Infantile acne'</a> below and  <a class="medical medical_review" href="/z/d/html/7458.html" rel="external">"Pathogenesis and clinical features of disorders of androgen action"</a>.)</p><p class="headingAnchor" id="H2592737054"><span class="h2">Cutibacterium acnes and inflammation</span><span class="headingEndMark"> — </span>The ability of <em>C. acnes</em>, the prominent commensal bacteria within the microbiome of pilosebaceous follicles [<a href="#rid7">7-9</a>], to activate innate and adaptive immune responses may contribute to the inflammatory response observed in acne. Sequencing of the <em>C. acnes</em> genome has led to the identification of bacterial properties that may contribute to inflammation and virulence [<a href="#rid10">10,11</a>]. Critical factors may include virulence-associated genes in certain <em>C. acnes</em> strains, <em>C. acnes</em> production of enzymes that promote degradation of the follicular wall and follicular rupture, and <em>C. acnes</em> surface proteins that trigger humoral and cell-mediated immune responses.</p><p>Strains of <em>C. acnes</em> associated with either acne (phylotype IA) or healthy skin (phylotypes II and III) have been identified [<a href="#rid12">12</a>]. The acne-associated strains are more likely to carry genes associated with antibiotic resistance [<a href="#rid8">8</a>]. Acne-associated strains also have a greater propensity to stimulate TH17 cells to secrete interferon (IFN)-gamma and proinflammatory interleukin (IL) 17, whereas healthy skin-associated strains stimulate TH17 cells to produce anti-inflammatory IL-10 [<a href="#rid13">13,14</a>]. Vitamin A and vitamin D may play regulatory roles in the <em>C. acnes</em>-induced IL-17 response; in an in vitro study, <em>C. acnes</em>-mediated IL-17 induction was inhibited by exposure of peripheral blood mononuclear cells to vitamin A or vitamin D [<a href="#rid13">13</a>].</p><p><em>C. acnes</em> activates the innate immune response to produce proinflammatory IL-1 via activation of the nod-like receptor P3 (NLRP3) inflammasome in human sebocytes and monocytes [<a href="#rid15">15,16</a>]. It also binds and activates toll-like receptor 2, located on perifollicular macrophages, and triggers the release of proinflammatory cytokines (including IL-8 and IL-12) [<a href="#rid17">17,18</a>]. These cytokines contribute to the attraction of neutrophils and the release of neutrophil lysosomal enzymes that promote follicular rupture (see  <a class="medical medical_review" href="/z/d/html/3985.html" rel="external">"Toll-like receptors: Roles in disease and therapy"</a>). Differences in the host inflammatory response to <em>C. acnes</em> or the pathogenicity of specific strains of <em>C. acnes</em> that colonize skin may contribute to the variation in the prevalence and severity of acne [<a href="#rid12">12,19</a>]. <em>C. acnes</em> may also form biofilms within follicles that could contribute to resistance to therapy [<a href="#rid20">20</a>].</p><p>Gene expression studies have been performed in the skin of patients with acne to further elucidate the inflammatory response. Upregulation of matrix metalloproteinases 1 and 3, inflammatory cytokines (IL-8), and antimicrobial peptides (human beta-defensin 4 and granzyme B) have been detected in inflammatory acne lesions [<a href="#rid21">21</a>]. In addition, human beta-defensin 2 immunoreactivity is highly upregulated in acne-affected skin, with human beta-defensin 1 also upregulated to a lesser degree [<a href="#rid22">22</a>].</p><p class="headingAnchor" id="H1472410770"><span class="h2">Genetics</span><span class="headingEndMark"> — </span>Individuals with close family members with acne are at increased risk for the disorder, supporting a genetic component to the disease [<a href="#rid3">3,23-25</a>]. Case-control studies have demonstrated a more than threefold risk among individuals with affected first-degree family members [<a href="#rid23">23,25,26</a>]. A large twin study of monozygotic and dizygotic twins also supported the heritable nature of acne [<a href="#rid27">27</a>]. An important role for genetics in mild acne is less certain due to the almost ubiquitous occurrence in young adolescents.</p><p class="headingAnchor" id="H2073229757"><span class="h1">ASSOCIATED FACTORS</span><span class="headingEndMark"> — </span>Proposed contributory factors for acne have included skin trauma, dietary habits, stress, insulin resistance, and body mass index. </p><p class="headingAnchor" id="H7"><span class="h2">Skin trauma</span><span class="headingEndMark"> — </span>Repetitive mechanical trauma caused by scrubbing affected skin with soaps, detergents, astringents, or other agents may worsen acne by rupturing comedones, promoting the development of inflammatory lesions [<a href="#rid28">28</a>]. </p><p class="headingAnchor" id="H8"><span class="h2">Diet</span><span class="headingEndMark"> — </span>The role of diet in acne is an evolving concept [<a href="#rid29">29-33</a>]. Several studies suggest an association between acne and increased milk consumption and high glycemic load diets. Increased levels of insulin-like growth factor (IGF) related to dairy consumption or high glycemic load diets and natural hormonal components of milk or other bioactive molecules in milk are hypothesized to play a role [<a href="#rid34">34-37</a>] (see <a class="local">'Insulin resistance'</a> below):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Milk consumption</strong> – A study of 47,355 women in the Nurses' Health Study that used retrospective data collection to determine diet during high school found an association between acne and intake of milk [<a href="#rid34">34</a>]. Two subsequent, large, prospective, cohort studies (one involving boys and the other involving girls) also reported an association of milk ingestion and acne [<a href="#rid38">38,39</a>]. All three studies were questionnaire-based, requiring subjects to recall their dietary intake and self-diagnose acne and disease severity. </p><p></p><p class="bulletIndent1">A case-control study of 205 patients with clinician-confirmed moderate to severe acne and 358 controls with mild or nonexistent acne also found an association between milk consumption (more than three portions per week) and moderate to severe acne (odds ratio [OR] 1.78, 95% CI 1.22-2.59) [<a href="#rid23">23</a>]. Similar to the other studies, food intake history was assessed via a retrospective patient questionnaire. </p><p></p><p class="bulletIndent1">A case-control study that used three 24-hour diet recall phone interviews to assess typical food intake in 120 teenagers (ages 14 to 19 years) with moderate facial acne and 105 teenagers without acne suggests that the association of acne with higher milk consumption may be limited to low-fat and skim milk [<a href="#rid40">40</a>]. The study did not find an association between acne and consumption of full-fat milk.</p><p></p><p class="bulletIndent1">A longitudinal, questionnaire-based, population study of Norwegian adolescents demonstrated an association between high intakes of dairy products and acne in adolescence [<a href="#rid41">41</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>High glycemic load diets</strong> – Glycemic load is a nutritional concept that refers to a measure of glycemic effect (glucose-raising potential) of dietary carbohydrates. </p><p></p><p class="bulletIndent1">A 12-week, randomized trial that compared low and high glycemic load diets in 43 male patients with acne found a greater reduction in lesion counts with the low glycemic load diet [<a href="#rid42">42</a>]. However, the participants on that diet also lost more weight than those on the high glycemic load diet, so it is possible that the improvement in acne was due to changes in weight rather than the composition of the diet. Additionally, a study of 20 subjects with altered metabolic profiles, randomized to a low glycemic load diet and <a class="drug drug_general" data-topicid="9621" href="/z/d/drug information/9621.html" rel="external">metformin</a> versus control, resulted in statistically significant improvements in both acne and metabolic parameters in the intervention group [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other factors </strong>– Although it is a common assumption that chocolate consumption increases severity of acne, a relationship between chocolate consumption and the prevalence or severity of acne has not been proven [<a href="#rid32">32</a>]. </p><p></p><p class="bulletIndent1">Data on favorable effects of dietary factors, such as zinc, omega-3 fatty acids, antioxidants, vitamin A, and dietary fiber, on acne vulgaris are limited [<a href="#rid44">44</a>]. Further studies are necessary to determine the roles of these supplements in acne vulgaris.</p><p></p><p class="headingAnchor" id="H9"><span class="h2">Stress</span><span class="headingEndMark"> — </span>Psychologic stress is often proposed as a potential exacerbating factor for acne [<a href="#rid45">45,46</a>]. Some studies have found an association between stress and increased acne severity.</p><p>A prospective cohort study in 94 secondary school students compared acne severity and sebum production at times of high stress (midterm examinations) and low stress (summer holidays) [<a href="#rid47">47</a>]. Sebum production did not appear to be related to stress, but increased acne severity, as assessed by an examiner blinded to the hypothesis of the study, did appear to be associated with stress, particularly in boys.</p><p>Similarly, a study of 22 university students found that greater acne severity appeared to correlate with increased perceived stress around the time of school examinations [<a href="#rid48">48</a>].</p><p class="headingAnchor" id="H3252532398"><span class="h2">Insulin resistance</span><span class="headingEndMark"> — </span>Insulin resistance may play a role in acne. Insulin resistance may stimulate increased androgen production and is associated with increased serum levels of insulin-like growth factor-1 (IGF-1), a finding linked to increased facial sebum excretion [<a href="#rid49">49</a>]. </p><p>There is a normal rise in insulin resistance and IGF-1 during puberty, the typical time of onset of acne. In addition, some studies have found higher serum IGF-1 levels in women with postadolescent acne than in women without acne [<a href="#rid50">50</a>] or a positive correlation between serum IGF-1 levels and acne lesion counts in women [<a href="#rid36">36</a>]. Moreover, a cross-sectional study of 100 postadolescent males with acne found a higher prevalence of insulin resistance in males with acne than in 100 age-matched controls (22 versus 11 percent) [<a href="#rid51">51</a>]. </p><p class="headingAnchor" id="H24192832"><span class="h2">Body mass index</span><span class="headingEndMark"> — </span>Studies evaluating the relationship between acne vulgaris and weight have yielded varied results, resulting in uncertainty regarding the relationship between these conditions [<a href="#rid23">23,52-56</a>]. One of the largest studies, a population-based study of over 600,000 Israeli adolescents and young adults (mean age 19 years), found an inverse relationship between excess weight and acne. As body mass index (BMI) increased, risk for acne progressively decreased, with diagnoses of acne in 20 and 16 percent of underweight (BMI &lt;18.5) males and females, respectively, compared with 13 and 11 percent of severely obese (BMI &gt;35) males and females, respectively [<a href="#rid55">55</a>]. The adjusted OR for acne in severely obese individuals was 0.53 (95% CI 0.42-0.64) for males and 0.5 (95% CI 0.37-0.62) for females. Individuals with a BMI of 18.5 to 22 were defined as the reference group.</p><p>In contrast, a case-control study of approximately 200 adolescents and young adults (ages 10 to 24) with moderate to severe acne and approximately 350 controls with no acne or mild acne found a correlation between low BMI and a reduced risk for moderate to severe acne that was most evident among males [<a href="#rid23">23</a>]. In addition, a cross-sectional, survey-based study of approximately 3600 young adults (ages 18 and 19) in Norway found an association between rising BMI and increased risk for acne among females [<a href="#rid53">53</a>].</p><p class="headingAnchor" id="H10"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H101769518"><span class="h2">Classic features</span><span class="headingEndMark"> — </span>The typical distribution of acne vulgaris correlates with areas of the body with large, hormonally responsive sebaceous glands, including the face, neck, chest, upper back, and upper arms. One or more types of active lesions may be present, including:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Closed comedones</strong> – Noninflammatory; &lt;5 mm; dome-shaped; smooth; skin-colored, whitish, or grayish papules  (<a class="graphic graphic_picture graphicRef62816" href="/z/d/graphic/62816.html" rel="external">picture 1B</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Open comedones</strong> – Noninflammatory, &lt;5 mm papules with a central, dilated, follicular orifice containing gray, brown, or black, keratotic material  (<a class="graphic graphic_picture graphicRef80536" href="/z/d/graphic/80536.html" rel="external">picture 1C</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Papulopustular acne</strong> – Inflamed, relatively superficial papules and pustules, typically &lt;5 mm in diameter  (<a class="graphic graphic_picture graphicRef98492 graphicRef70809" href="/z/d/graphic/98492.html" rel="external">picture 1A, 1G</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nodular acne </strong>– Deep-seated, inflamed, often tender, large papules (≥0.5 cm) or nodules (≥1 cm)  (<a class="graphic graphic_picture graphicRef57925 graphicRef59878" href="/z/d/graphic/57925.html" rel="external">picture 1I, 1L</a>)</p><p></p><p>Nodular acne is sometimes inaccurately referred to as "cystic" or "nodulocystic" acne. In reality, true cysts are rare.</p><p>Skin pigmentation may mask the characteristic erythema of inflamed lesions in patients with highly pigmented skin  (<a class="graphic graphic_picture graphicRef59878" href="/z/d/graphic/59878.html" rel="external">picture 1I</a>).</p><p>The extent and severity of skin involvement varies widely, ranging from the periodic appearance of a few small comedones to the chronic presence of numerous inflamed nodules involving the majority of skin in an affected region  (<a class="graphic graphic_picture graphicRef57925 graphicRef55681" href="/z/d/graphic/57925.html" rel="external">picture 1L-M</a>). Patient characteristics may influence the likelihood of certain presentations. Preadolescent and young adolescent patients often present with comedonal acne involving the T-zone (involving the forehead, nose, and chin). As the acne progresses, adolescents may develop inflammatory lesions  (<a class="graphic graphic_picture graphicRef62816 graphicRef70809" href="/z/d/graphic/62816.html" rel="external">picture 1B, 1G</a>). Adult women may present with acne involving the lower face and neck that is often associated with premenstrual flares  (<a class="graphic graphic_picture graphicRef98492 graphicRef81177" href="/z/d/graphic/98492.html" rel="external">picture 1A, 1N</a>) [<a href="#rid57">57,58</a>]. Premenstrual flares of acne appear to be more common in women over the age of 33 than in women aged 20 to 33 years [<a href="#rid59">59</a>]. (See  <a class="medical medical_review" href="/z/d/html/13615.html" rel="external">"Postadolescent acne in women"</a>.)</p><p>Estimations of acne severity are patient-specific and depend on a number of factors. The clinical type of lesions, presence of scarring, presence of draining lesions or sinus tracts, lack of therapeutic response, and the psychologic impact of acne are some of the features taken into account [<a href="#rid60">60</a>]. As an example, patients with inflammatory, nodular acne are often considered to have severe acne. Similarly, a patient without nodules but who has numerous inflammatory papules and pustules and notable scarring could also be classified as having severe disease.</p><p class="headingAnchor" id="H473652611"><span class="h2">Common sequelae</span><span class="headingEndMark"> — </span>Resolution of individual acne lesions may leave transient or permanent changes on the skin. Postinflammatory hyperpigmentation and scarring are common sequelae that can be highly distressing for patients.</p><p class="headingAnchor" id="H3753831729"><span class="h3">Postinflammatory hyperpigmentation</span><span class="headingEndMark"> — </span>As with other inflammatory skin conditions, acne vulgaris may lead to the development of hyperpigmentation at the site of an active or resolving lesion. The risk for hyperpigmentation increases with increasing baseline skin pigmentation and is particularly common in individuals with skin phototypes IV to VI  (<a class="graphic graphic_table graphicRef60541" href="/z/d/graphic/60541.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/z/d/html/95847.html" rel="external">"Postinflammatory hyperpigmentation"</a>.)</p><p>Postinflammatory hyperpigmentation typically resolves spontaneously, but an individual hyperpigmented macule may persist for several months or longer without treatment. As a result, even patients with relatively mild, active acne can exhibit postinflammatory hyperpigmentation as a prominent disfiguring feature  (<a class="graphic graphic_picture graphicRef58817" href="/z/d/graphic/58817.html" rel="external">picture 2C</a>).</p><p class="headingAnchor" id="H2736573465"><span class="h3">Scarring</span><span class="headingEndMark"> — </span>Acne scarring is a common consequence of acne vulgaris that occurs in some patients. Inflammatory acne is considered more likely to result in scarring than noninflammatory acne. Why scarring occurs in some patients and not others despite similar manifestations of acne vulgaris is not clear. (See  <a class="medical medical_review" href="/z/d/html/90260.html" rel="external">"Management of acne scars", section on 'Pathogenesis'</a>.) </p><p>Various types of scars can result from acne vulgaris, including atrophic scars (ice pick scars, rolling scars, and boxcar scars), hypertrophic scars, and keloids  (<a class="graphic graphic_picture graphicRef66410 graphicRef61382" href="/z/d/graphic/66410.html" rel="external">picture 2A-B</a>). The features of acne scars are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/90260.html" rel="external">"Management of acne scars", section on 'Classification'</a>.)</p><p class="headingAnchor" id="H4157234745"><span class="h2">Variants</span><span class="headingEndMark"> — </span>Occasional variants of acne vulgaris include acne conglobata and acne excoriée.</p><p class="headingAnchor" id="H3983400395"><span class="h3">Acne conglobata</span><span class="headingEndMark"> — </span>Acne conglobata is a severe form of nodular acne that most often occurs in young males  (<a class="graphic graphic_picture graphicRef55681" href="/z/d/graphic/55681.html" rel="external">picture 1M</a>). Skin involvement tends to be most prominent on the back, chest, and buttocks but can also appear on the face or other sites. Large, draining lesions; sinus tracts; and severe scarring may occur. Sinus tracts manifest as fluctuant, linear lesions and are formed when nodules merge. Systemic symptoms are absent. </p><p>Acne conglobata is distinct from acne fulminans, an acute condition characterized by nodules, friable plaques, erosions, and ulcers. (See <a class="local">'Acne fulminans'</a> below.)</p><p>The treatment of acne conglobata is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/129467.html" rel="external">"Acne vulgaris: Management of moderate to severe acne in adolescents and adults", section on 'Acne conglobata'</a>.)</p><p class="headingAnchor" id="H2291014827"><span class="h3">Acne excoriée</span><span class="headingEndMark"> — </span>Acne excoriée typically presents with relatively mild acne comedones or inflammatory papules that are chronically and obsessively picked and excoriated, leading to erosions and scarring  (<a class="graphic graphic_picture graphicRef73615" href="/z/d/graphic/73615.html" rel="external">picture 3</a>). This condition is often, but not always, seen in young women. An underlying psychiatric disorder can be associated, and treatment may involve antidepressants and psychotherapy. (See  <a class="medical medical_review" href="/z/d/html/13698.html" rel="external">"Skin picking (excoriation) disorder and related disorders"</a>.)</p><p class="headingAnchor" id="H1595735766"><span class="h3">Infantile acne</span><span class="headingEndMark"> — </span>Infantile acne typically begins between ages three to six months and results from elevated levels of androgens produced by the immature adrenal gland in girls and the immature adrenal gland and testes in boys. Androgen levels fall by age one to two and is accompanied by improvement in acne. (See  <a class="medical medical_review" href="/z/d/html/5790.html" rel="external">"Vesicular, pustular, and bullous lesions in the newborn and infant", section on 'Infantile acne'</a>.)</p><p class="headingAnchor" id="H42110619"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Potential complications of acne vulgaris include psychosocial dysfunction, gram-negative folliculitis, acne fulminans, and solid facial edema.</p><p class="headingAnchor" id="H1090501115"><span class="h2">Psychologic effects</span><span class="headingEndMark"> — </span>Acne vulgaris can contribute to significant psychologic morbidity and, rarely, to mortality due to suicide [<a href="#rid61">61,62</a>]. Embarrassment, anxiety, and lowered self-esteem related to the appearance of affected skin or disfiguring scars can impact the social lives and employment of affected individuals. </p><p class="headingAnchor" id="H1491904048"><span class="h2">Gram-negative folliculitis</span><span class="headingEndMark"> — </span>Patients with acne vulgaris who have been treated with long-term systemic antibiotics (usually tetracyclines) may develop gram-negative folliculitis. These patients exhibit an initial response to the oral antibiotic, followed by apparent resistance to the treatment and worsening of acne. </p><p>Inflammatory papules, pustules, and nodules typically appear on perinasal skin and the central face. A culture of lesions will yield gram-negative organisms, such as <em>Enterobacter</em>, <em>Klebsiella</em>, <em>Pseudomonas</em>, <em>Proteus</em>, or <em>Escherichia</em> species. (See  <a class="medical medical_review" href="/z/d/html/103297.html" rel="external">"Infectious folliculitis", section on 'Bacterial folliculitis'</a>.)</p><p class="headingAnchor" id="H13"><span class="h2">Acne fulminans</span><span class="headingEndMark"> — </span>Acne fulminans is a disorder characterized by an acute eruption of large, inflammatory nodules and friable plaques with erosions, ulcers, and hemorrhagic crusts  (<a class="graphic graphic_picture graphicRef64372" href="/z/d/graphic/64372.html" rel="external">picture 4</a>). This rare condition primarily affects adolescent males with pre-existing acne vulgaris. Acne fulminans may be triggered by <a class="drug drug_general" data-topicid="8582" href="/z/d/drug information/8582.html" rel="external">isotretinoin</a> therapy or may occur spontaneously. The pathogenesis is unclear. Lesions usually involve the trunk but may be present elsewhere.</p><p>Acne fulminans may occur in association with systemic symptoms (eg, fever, malaise, bone pain, arthralgias), erythema nodosum, and laboratory and radiologic abnormalities [<a href="#rid63">63</a>]. Potential laboratory abnormalities include leukocytosis, anemia, and an elevated erythrocyte sedimentation rate or C-reactive protein. Radiographs may reveal osteolytic lesions of the bone, particularly in the sternum, clavicles, sacroiliac joints, or hips. </p><p>A proposed classification system for acne fulminans divides the condition into four variants [<a href="#rid63">63</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acne fulminans with systemic symptoms</strong> –<strong> </strong>Skin manifestations (abrupt, dramatic flare of inflammatory acne with erosions, crusts, ulcers, and hemorrhagic nodules or plaques) are accompanied by systemic symptoms, laboratory abnormalities, or osteolytic bone lesions.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acne fulminans without systemic symptoms</strong> – Skin manifestations are similar to acne fulminans with systemic symptoms, but systemic findings are absent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Isotretinoin</strong><strong>-induced acne fulminans with systemic symptoms</strong> – Drug-induced form of acne fulminans with systemic findings; skin manifestations are similar to the other variants.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Isotretinoin</strong><strong>-induced acne fulminans without systemic symptoms</strong> – Drug-induced form of acne fulminans without systemic findings; skin manifestations are similar to the other variants.</p><p></p><p>Isotretinoin-induced acne fulminans without systemic symptoms is the most common type of acne fulminans [<a href="#rid63">63</a>].</p><p>The evaluation and treatment of patients with acne fulminans are reviewed separately. (See <a class="local">'Additional tests'</a> below and  <a class="medical medical_review" href="/z/d/html/129467.html" rel="external">"Acne vulgaris: Management of moderate to severe acne in adolescents and adults", section on 'Acne fulminans'</a>.)</p><p class="headingAnchor" id="H2949950088"><span class="h2">Solid facial edema</span><span class="headingEndMark"> — </span>Solid facial edema (Morbihan's disease) is a rare complication of acne that presents as facial soft tissue edema and erythema. The condition may wax and wane in severity but usually does not spontaneously resolve without treatment. Improvement with <a class="drug drug_general" data-topicid="8582" href="/z/d/drug information/8582.html" rel="external">isotretinoin</a> with or without <a class="drug drug_general" data-topicid="16764" href="/z/d/drug information/16764.html" rel="external">ketotifen</a>, systemic glucocorticoids, or <a class="drug drug_general" data-topicid="107872" href="/z/d/drug information/107872.html" rel="external">clofazimine</a> has been reported [<a href="#rid64">64</a>].</p><p class="headingAnchor" id="H3411636856"><span class="h1">ASSOCIATED DISEASES</span><span class="headingEndMark"> — </span>Hyperandrogenism, a condition that may occur in disorders such as polycystic ovarian syndrome, late-onset adrenal hyperplasia, and adrenal or ovarian tumors, may cause acne. Polycystic ovarian syndrome is the most common cause of hyperandrogenism in women. (See  <a class="medical medical_review" href="/z/d/html/5852.html" rel="external">"Definition, clinical features, and differential diagnosis of polycystic ovary syndrome in adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/7430.html" rel="external">"Epidemiology, phenotype, and genetics of the polycystic ovary syndrome in adults"</a> and  <a class="medical medical_review" href="/z/d/html/147.html" rel="external">"Diagnosis and treatment of nonclassic (late-onset) congenital adrenal hyperplasia due to 21-hydroxylase deficiency"</a> and  <a class="medical medical_review" href="/z/d/html/123.html" rel="external">"Adrenal hyperandrogenism"</a> and  <a class="medical medical_review" href="/z/d/html/7458.html" rel="external">"Pathogenesis and clinical features of disorders of androgen action"</a>.)</p><p>Examples of rare syndromes that may include acne as a feature include SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome and PAPA (sterile pyogenic arthritis, pyoderma gangrenosum, and acne) syndrome. Patients with SAPHO syndrome exhibit features of inflammatory arthritis or osteitis, particularly of the anterior chest wall. (See  <a class="medical medical_review" href="/z/d/html/99510.html" rel="external">"SAPHO (synovitis, acne, pustulosis, hyperostosis, osteitis) syndrome"</a> and  <a class="medical medical_review" href="/z/d/html/5597.html" rel="external">"The autoinflammatory diseases: An overview"</a>.)</p><p class="headingAnchor" id="H2871094629"><span class="h1">DIAGNOSIS AND EVALUATION</span><span class="headingEndMark"> — </span>The diagnosis of acne vulgaris is generally made based upon the physical examination. There are no laboratory tests that confirm a diagnosis of acne vulgaris. The need for laboratory or radiologic tests is generally limited to patients for whom the clinical evaluation suggests underlying hyperandrogenism or other specific conditions warranting additional testing. Skin biopsies are not typically necessary. (See  <a class="medical medical_review" href="/z/d/html/42.html" rel="external">"Acne vulgaris: Overview of management"</a>.)</p><p class="headingAnchor" id="H3852278797"><span class="h2">History</span><span class="headingEndMark"> — </span>The patient history is an important component of the evaluation. The history is particularly helpful for identifying patients with acne caused or exacerbated by an exposure (eg, drug-induced acne) or who may need further evaluation for associated disease (eg, hyperandrogenism, SAPHO [synovitis, acne, pustulosis, hyperostosis, and osteitis] syndrome, acne fulminans). Information gleaned from the patient history may also be helpful for guiding treatment. (See  <a class="medical medical_review" href="/z/d/html/42.html" rel="external">"Acne vulgaris: Overview of management", section on 'Pretreatment assessment'</a>.)</p><p>Helpful information includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Age of onset and current age</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Medication history  (<a class="graphic graphic_table graphicRef76762" href="/z/d/graphic/76762.html" rel="external">table 3</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Menstrual history in females (frequency, association with acne flares)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Medical history</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Family history of acne</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Signs of virilization in young children or females (hirsutism, male pattern hair loss, genital enlargement, deepening of voice)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Joint, bone, or systemic symptoms in patients with severe acne</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Skin care regimen (use of occlusive or comedogenic products)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Current and prior treatments and response</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Psychologic impact of acne</p><p></p><p class="headingAnchor" id="H1894226835"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>The diagnosis is based upon the recognition of characteristic lesions (closed comedones, open comedones, inflammatory papules, inflammatory pustules, inflamed nodules) in a characteristic distribution (eg, face, chest, shoulders, back, or upper arms) during the skin examination. </p><p>Helpful factors to assess on the skin examination include:</p><p class="bulletIndent1"><span class="glyph">●</span>Lesion type and distribution</p><p class="bulletIndent1"><span class="glyph">●</span>Lesion stages (monomorphous versus polymorphous)</p><p class="bulletIndent1"><span class="glyph">●</span>Signs of hyperandrogenism in young children and females (hirsutism, male pattern hair loss)</p><p class="bulletIndent1"><span class="glyph">●</span>Presence of sequelae of acne vulgaris, including postinflammatory hyperpigmentation and scarring</p><p></p><p>The identification of comedones with or without other lesion types strongly supports the diagnosis. In addition, acne lesions are generally in various stages of development and resolution, in contrast to some presentations of drug-induced acne, which exhibit the acute development of monomorphous lesions. <em>Pityrosporum</em> folliculitis, a condition in the differential diagnosis of acne vulgaris, also often presents with monomorphous inflammatory lesions. (See <a class="local">'Trunk and extremities'</a> below and  <a class="medical medical_review" href="/z/d/html/103297.html" rel="external">"Infectious folliculitis", section on 'Fungal folliculitis'</a>.)</p><p class="headingAnchor" id="H2184780667"><span class="h2">Additional tests</span><span class="headingEndMark"> — </span>Laboratory tests and radiologic imaging is not indicated for the vast majority of patients with acne vulgaris. Indications for testing are primarily limited to patients who exhibit signs of associated disease or acne fulminans.</p><p>Populations in whom testing is advised include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with signs of hyperandrogenism</strong> – Assessment for hyperandrogenism is indicated for patients exhibiting additional signs suggestive of androgen excess, such as may occur in polycystic ovarian syndrome, congenital adrenal hyperplasia, and adrenal or ovarian tumors [<a href="#rid65">65</a>]. Clinical findings that support an evaluation include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Irregular or infrequent menses in females</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hirsutism</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Signs of virilization in females or prepubertal males (male pattern hair loss, clitoromegaly, increased muscle mass, deepening of voice  (<a class="graphic graphic_picture graphicRef80117" href="/z/d/graphic/80117.html" rel="external">picture 5</a>))</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Development of mid-childhood acne (onset between one and six years of age)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Abrupt onset of severe, atypical, recalcitrant acne</p><p></p><p class="bulletIndent1">Other signs that may suggest androgen excess in prepubertal children include early-onset body odor, early development of axillary or pubic hair, accelerated growth, advanced bone age, and genital maturation [<a href="#rid65">65</a>]. An endocrinologic work-up is usually not necessary for children with preadolescent acne (ages 7 to 12 years) in the absence of other clinical signs of hyperandrogenism [<a href="#rid66">66,67</a>]. (See  <a class="medical medical_review" href="/z/d/html/131570.html" rel="external">"Acne in infants, young children, and preadolescents", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1">Recommendations for the evaluation for hyperandrogenism vary based upon the clinical presentation: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Premenopausal adolescent or adult females with oligomenorrhea without virilization:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/z/d/html/94182.html" rel="external">"Diagnostic evaluation of polycystic ovary syndrome in adolescents", section on 'Basic diagnostic approach'</a>.)</p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/z/d/html/7385.html" rel="external">"Diagnosis of polycystic ovary syndrome in adults", section on 'Evaluation'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Premenopausal adolescent or adult females with hirsutism without oligomenorrhea or virilization:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/z/d/html/7441.html" rel="external">"Evaluation of premenopausal women with hirsutism", section on 'Hirsutism and normal menstrual cycles'</a>.)</p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/z/d/html/13917.html" rel="external">"Evaluation and management of postmenopausal hyperandrogenism"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Premenopausal adolescent or adult females with virilization:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/z/d/html/7441.html" rel="external">"Evaluation of premenopausal women with hirsutism", section on 'Severe hyperandrogenism'</a>.)</p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/z/d/html/7441.html" rel="external">"Evaluation of premenopausal women with hirsutism", section on 'Additional evaluation for severe hyperandrogenemia'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Postmenopausal women with hirsutism or virilization:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/z/d/html/13917.html" rel="external">"Evaluation and management of postmenopausal hyperandrogenism"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Children with mid-childhood acne or features suggestive of androgen excess:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>(See  <a class="medical medical_review" href="/z/d/html/131570.html" rel="external">"Acne in infants, young children, and preadolescents", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1">The abrupt onset of severe, atypical, or recalcitrant acne should prompt consideration of hyperandrogenism induced by adrenal or ovarian tumors. Laboratory tests and radiologic imaging may be necessary. (See  <a class="medical medical_review" href="/z/d/html/137.html" rel="external">"Clinical presentation and evaluation of adrenocortical tumors", section on 'Diagnostic evaluation'</a> and  <a class="medical medical_review" href="/z/d/html/7441.html" rel="external">"Evaluation of premenopausal women with hirsutism"</a> and  <a class="medical medical_review" href="/z/d/html/13917.html" rel="external">"Evaluation and management of postmenopausal hyperandrogenism"</a> and  <a class="medical medical_review" href="/z/d/html/7397.html" rel="external">"Ovarian hyperthecosis"</a> and  <a class="medical medical_review" href="/z/d/html/16833.html" rel="external">"Sex cord-stromal tumors of the ovary: Epidemiology, clinical features, and diagnosis in adults"</a>.)</p><p></p><p class="bulletIndent1">Patients in whom initial tests reveal abnormalities may be referred to endocrinology, gynecology, or other specialists, as needed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with acne fulminans</strong> – The following evaluation is suggested for patients with clinical findings consistent with acne fulminans to assess for systemic involvement and in preparation for <a class="drug drug_general" data-topicid="8582" href="/z/d/drug information/8582.html" rel="external">isotretinoin</a> therapy [<a href="#rid63">63</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Complete blood count with differential</p><p class="bulletIndent2"><span class="glyph">•</span>Liver function tests</p><p class="bulletIndent2"><span class="glyph">•</span>Erythrocyte sedimentation rate and C-reactive protein in patients with systemic findings</p><p class="bulletIndent2"><span class="glyph">•</span>Serum cholesterol and triglycerides</p><p class="bulletIndent2"><span class="glyph">•</span>Urine or serum pregnancy test (in women)</p><p class="bulletIndent2"><span class="glyph">•</span>Radiograph (if symptoms suggestive of bone or joint involvement are present)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with musculoskeletal symptoms suggestive of SAPHO syndrome</strong> – SAPHO syndrome should be suspected in patients in whom moderate to severe nodular acne is accompanied by symptoms of arthritis or osteitis, particularly when involving the chest wall. The assessment of patients with SAPHO syndrome is reviewed separately. (See <a class="local">'Associated diseases'</a> above and  <a class="medical medical_review" href="/z/d/html/99510.html" rel="external">"SAPHO (synovitis, acne, pustulosis, hyperostosis, osteitis) syndrome", section on 'Diagnosis'</a>.)</p><p></p><p class="headingAnchor" id="H25"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Although acne vulgaris is a common and often easily diagnosed condition, the possibility of other disorders, including other skin diseases and acneiform eruptions, should always be considered. Important diagnoses to consider include other skin diseases that induce inflammatory or noninflammatory skin lesions and acneiform eruptions, nonacne disorders that closely resemble acne.</p><p class="headingAnchor" id="H380680823"><span class="h2">Inflammatory facial lesions</span><span class="headingEndMark"> — </span>Examples of disorders in the differential diagnosis of facial inflammatory acne lesions include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rosacea </strong>– Common features of rosacea include erythema, telangiectasias, and papules or pustules on the central face  (<a class="graphic graphic_picture graphicRef78747" href="/z/d/graphic/78747.html" rel="external">picture 6</a>). Acne vulgaris is distinguished from rosacea by the presence of comedones and the absence of telangiectasias  (<a class="graphic graphic_figure graphicRef135142" href="/z/d/graphic/135142.html" rel="external">figure 3</a>). (See  <a class="medical medical_review" href="/z/d/html/13621.html" rel="external">"Rosacea: Pathogenesis, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Periorificial dermatitis </strong>– Periorificial dermatitis (also known as perioral dermatitis) is characterized by small, grouped, erythematous papules in a perioral (or occasionally perinasal or periorbital) distribution  (<a class="graphic graphic_picture graphicRef64577 graphicRef120217" href="/z/d/graphic/64577.html" rel="external">picture 7A-B</a>). When the perioral skin is involved, a rim of spared skin is usually seen around the vermilion border of the lip. (See  <a class="medical medical_review" href="/z/d/html/13622.html" rel="external">"Perioral (periorificial) dermatitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong><em>Demodex</em></strong><strong> folliculitis</strong> – <em>Demodex</em> folliculitis often presents as inflammatory papules and pustules on the face  (<a class="graphic graphic_picture graphicRef128984" href="/z/d/graphic/128984.html" rel="external">picture 8</a>). The diagnosis is often made when patients fail to respond to treatments for rosacea or acne. An oil preparation demonstrating multiple <em>Demodex</em> mites provides support for the diagnosis  (<a class="graphic graphic_picture graphicRef128983" href="/z/d/graphic/128983.html" rel="external">picture 9</a>). However, clinical correlation is necessary because <em>Demodex</em> mites can also be found on normal skin, and increased numbers of mites are associated with papulopustular rosacea and periorificial dermatitis. (See  <a class="medical medical_review" href="/z/d/html/103297.html" rel="external">"Infectious folliculitis", section on 'Demodex folliculitis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pseudofolliculitis barbae </strong>– Pseudofolliculitis barbae occurs most commonly in individuals with tightly curled hair. Inflammatory papules and pustules occur in the beard area and may result in keloidal scarring. It is thought that short, shaved or clipped hairs in the beard area curl back towards the skin, penetrate the skin, and cause a foreign body inflammatory reaction  (<a class="graphic graphic_picture graphicRef69365 graphicRef76686" href="/z/d/graphic/69365.html" rel="external">picture 10A-B</a>). (See  <a class="medical medical_review" href="/z/d/html/3323.html" rel="external">"Pseudofolliculitis barbae"</a> and  <a class="medical medical_review" href="/z/d/html/5569.html" rel="external">"Keloids and hypertrophic scars"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Facial angiofibromas in tuberous sclerosis </strong>– Facial angiofibromas associated with tuberous sclerosis usually appear in childhood. These lesions commonly present as persistent, 1 to 3 mm, pink or red papules on the nose and medial cheeks  (<a class="graphic graphic_picture graphicRef54868" href="/z/d/graphic/54868.html" rel="external">picture 11</a>). (See  <a class="medical medical_review" href="/z/d/html/6175.html" rel="external">"Tuberous sclerosis complex: Clinical features"</a>.) </p><p></p><p class="headingAnchor" id="H3971916834"><span class="h2">Noninflammatory facial lesions</span><span class="headingEndMark"> — </span>Examples of disorders in the differential diagnosis of facial noninflammatory acne lesions include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sebaceous hyperplasia </strong>– Visible enlargement of sebaceous glands is termed "sebaceous hyperplasia." It most commonly occurs in adults with a history of oily skin. These growths are umbilicated, yellowish papules most commonly found on the forehead and cheeks  (<a class="graphic graphic_picture graphicRef98390 graphicRef98389" href="/z/d/graphic/98390.html" rel="external">picture 12A-B</a>). These lesions may resemble basal cell carcinomas. (See  <a class="medical medical_review" href="/z/d/html/16910.html" rel="external">"Cutaneous adnexal tumors", section on 'Sebaceous hyperplasia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nevus comedonicus </strong>– Nevus comedonicus appears at birth or in childhood and exhibits a grouped or linear arrangement of comedones  (<a class="graphic graphic_picture graphicRef122957" href="/z/d/graphic/122957.html" rel="external">picture 13</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adnexal tumors </strong>– Benign follicular tumors, such as trichoepitheliomas, trichodiscomas, or fibrofolliculomas, typically present as flesh-colored facial papules. (See  <a class="medical medical_review" href="/z/d/html/16910.html" rel="external">"Cutaneous adnexal tumors"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Favre-Racouchot syndrome </strong>– Favre-Racouchot syndrome is a condition resulting from cutaneous photodamage (sun damage) seen in middle-aged or older adults. Open and closed comedos are found in areas of photodamage, usually on the lateral upper cheeks  (<a class="graphic graphic_picture graphicRef59339" href="/z/d/graphic/59339.html" rel="external">picture 14</a>).</p><p></p><p class="headingAnchor" id="H2470006297"><span class="h2">Trunk and extremities</span><span class="headingEndMark"> — </span>Examples of disorders that may present with lesions resembling acne vulgaris on the trunk or extremities include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Folliculitis </strong>– Staphylococcal, eosinophilic, pseudomonal, or <em>Pityrosporum</em> folliculitis may mimic inflammatory acne  (<a class="graphic graphic_picture graphicRef103499 graphicRef98256 graphicRef86997 graphicRef117249" href="/z/d/graphic/103499.html" rel="external">picture 15A-D</a>). Comedos are absent, and lesions are usually monomorphous, unlike the polymorphous lesions in different stages of development that are typical of acne. (See  <a class="medical medical_review" href="/z/d/html/103297.html" rel="external">"Infectious folliculitis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Keratosis pilaris </strong>– In this common condition caused by keratotic, follicular plugging, patients typically present with small, follicular papules on the extensor surfaces of the upper arms or thighs  (<a class="graphic graphic_picture graphicRef68488 graphicRef60786" href="/z/d/graphic/68488.html" rel="external">picture 16A-B</a>). Erythema may be present. Lesions can also occur on the face, particularly in children. (See  <a class="medical medical_review" href="/z/d/html/13663.html" rel="external">"Keratosis pilaris"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hidradenitis suppurativa</strong> – Hidradenitis suppurativa is a chronic inflammatory skin disorder characterized by recurrent, inflamed nodules and abscesses with a predilection for intertriginous skin areas, such as the axilla, groin, perianal, perineal, and inframammary regions  (<a class="graphic graphic_picture graphicRef114609" href="/z/d/graphic/114609.html" rel="external">picture 17</a>). Additional features include comedones, sinus tracts, and scarring. (See  <a class="medical medical_review" href="/z/d/html/5575.html" rel="external">"Hidradenitis suppurativa: Pathogenesis, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Steatocystoma multiplex </strong>– Steatocystoma multiplex is an autosomal dominant or sporadic genetic disorder in which multiple yellow or skin-colored, sebum-filled cysts are found on the trunk, upper arms, or chest  (<a class="graphic graphic_picture graphicRef71097" href="/z/d/graphic/71097.html" rel="external">picture 18</a>). (See  <a class="medical medical_review" href="/z/d/html/5573.html" rel="external">"Overview of benign lesions of the skin", section on 'Steatocystoma multiplex'</a>.)</p><p></p><p class="headingAnchor" id="H27"><span class="h2">Acneiform eruptions</span><span class="headingEndMark"> — </span>There are multiple disorders in which acne-like eruptions occur, unassociated with true acne vulgaris. These include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Drug-induced acne</strong> – Drug-induced acne typically presents with a monomorphous, inflammatory, papular eruption (as opposed to the polymorphous eruption with lesions in varying stages seen with acne vulgaris)  (<a class="graphic graphic_picture graphicRef86995 graphicRef86994" href="/z/d/graphic/86995.html" rel="external">picture 19A-B</a>). Medications associated with drug-induced acne are listed in a table  (<a class="graphic graphic_table graphicRef76762" href="/z/d/graphic/76762.html" rel="external">table 3</a>). Glucocorticoid-induced eruptions are also referred to as "steroid folliculitis." (See  <a class="medical medical_review" href="/z/d/html/5565.html" rel="external">"Topical corticosteroids: Use and adverse effects", section on 'Cutaneous'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neonatal cephalic pustulosis </strong>– Neonatal cephalic pustulosis (previously called neonatal acne) presents with inflammatory papules and pustules on the face in the absence of comedones. Neonatal cephalic pustulosis is distinct from infantile acne. Neonatal cephalic pustulosis appears within the first few weeks of life  (<a class="graphic graphic_picture graphicRef56615" href="/z/d/graphic/56615.html" rel="external">picture 20</a>); infantile acne usually appears around three to six months of age. (See  <a class="medical medical_review" href="/z/d/html/119230.html" rel="external">"Skin lesions in the newborn and infant", section on 'Neonatal cephalic pustulosis (neonatal acne)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acne cosmetica</strong> – Cosmetic products that contain comedogenic ingredients can induce the formation of acne lesions. This type of acne has lessened as products designed to be less comedogenic have become widely available. Heavy, oil-based hair products are still commonly used and may contribute to the development of acne on the forehead (pomade acne).</p><p></p><p class="bulletIndent1">Irritant reactions to cosmetic products can also produce eruptions that resemble acne vulgaris. Inflammatory papules or pustules may occur within hours after the application of the inciting product.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acne mechanica </strong>– Worn items, such as turtlenecks, bra straps, shoulder pads, orthopedic casts, and sports helmets, may irritate pilosebaceous follicles, stimulating comedo formation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occupational acne and chloracne</strong> – Comedones, inflammatory papules, pustules, nodules, or cysts can occur in response to exposure to certain chemicals, including insoluble cutting oils, <a class="drug drug_general" data-topicid="8878" href="/z/d/drug information/8878.html" rel="external">coal tar</a> derivatives, and chlorinated hydrocarbons. "Chloracne" is the term used to describe acne that occurs with exposure to chlorinated hydrocarbons (eg, dioxin) via percutaneous contact, inhalation, or ingestion. Clinically, chloracne is characterized by large, monomorphic comedos with evolution into severely inflammatory and scarring lesions. Chloracne is most common on the face, neck, postauricular skin, axillae, and scrotum, although other sites may be involved.</p><p></p><p class="headingAnchor" id="H3186079444"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/114928.html" rel="external">"Society guideline links: Acne vulgaris"</a>.)</p><p class="headingAnchor" id="H34"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/15326.html" rel="external">"Patient education: Acne (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/7634.html" rel="external">"Patient education: Acne (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H35"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> – Acne vulgaris is a common skin condition in adolescents and young adults that may also occur at other ages. The clinical manifestations of acne vulgaris vary widely, and the psychologic impact can be significant. (See <a class="local">'Epidemiology'</a> above and  <a class="medical medical_review" href="/z/d/html/131570.html" rel="external">"Acne in infants, young children, and preadolescents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – Acne vulgaris is a disorder of the pilosebaceous follicles (see <a class="local">'Pathogenesis'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Lesion development</strong> – Follicular hyperkeratinization, sebum productio<em>n, Cutibacterium acnes</em>, and inflammation are involved in the pathogenesis. The temporal sequence of events leading to the formation of acne lesions is unknown but likely involves both host factors and dysbiosis within the microbiome of the pilosebaceous follicle. (See <a class="local">'Lesion development'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Role of androgens</strong> – Androgens induce sebum production and are an important factor in the development of acne vulgaris. Hyperandrogenism may cause acne, but most patients with acne vulgaris do not have androgen excess. (See <a class="local">'Sebaceous glands and the role of androgens'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Role of diet</strong> – The role of diet in acne vulgaris is an evolving concept. A contributory effect of milk and high glycemic index diets has been proposed, but prospective trials are necessary to clarify the relationship between diet and acne. (See <a class="local">'Diet'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Typically, acne vulgaris occurs on areas of the body with hormonally sensitive sebaceous glands, including the face, neck, chest, upper back, and upper arms. Open comedones, closed comedones, and inflammatory papules, pustules, or nodules are the characteristic lesions  (<a class="graphic graphic_picture graphicRef98492 graphicRef62816 graphicRef80536 graphicRef129596 graphicRef129597 graphicRef117250 graphicRef70809 graphicRef98493 graphicRef59878 graphicRef115821" href="/z/d/graphic/98492.html" rel="external">picture 1A-J</a>). (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sequelae and complications</strong> – Common sequelae of acne vulgaris include postinflammatory hyperpigmentation and scarring  (<a class="graphic graphic_picture graphicRef58817 graphicRef66410 graphicRef61382" href="/z/d/graphic/58817.html" rel="external">picture 2A-C</a>). Acne fulminans is a serious complication of acne vulgaris that may present as an acute eruption of inflamed nodules and friable plaques and systemic symptoms. Other cutaneous complications of acne vulgaris include gram-negative folliculitis and solid facial edema. (See <a class="local">'Common sequelae'</a> above and <a class="local">'Complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of acne vulgaris rests upon the patient's history and physical examination. Laboratory tests are not necessary for most patients. Patients with additional clinical findings suggestive of hyperandrogenism should be tested for androgen excess. (See <a class="local">'Diagnosis and evaluation'</a> above and  <a class="medical medical_review" href="/z/d/html/131570.html" rel="external">"Acne in infants, young children, and preadolescents", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – Although acne vulgaris is often easily diagnosed, the differential diagnosis includes a wide variety of skin diseases and acneiform eruptions  (<a class="graphic graphic_figure graphicRef135142" href="/z/d/graphic/135142.html" rel="external">figure 3</a>). (See <a class="local">'Differential diagnosis'</a> above and  <a class="medical medical_review" href="/z/d/html/131570.html" rel="external">"Acne in infants, young children, and preadolescents", section on 'Differential diagnosis'</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Stathakis V, Kilkenny M, Marks R. Descriptive epidemiology of acne vulgaris in the community. Australas J Dermatol 1997; 38:115.</a></li><li><a class="nounderline abstract_t">Collier CN, Harper JC, Cafardi JA, et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol 2008; 58:56.</a></li><li><a class="nounderline abstract_t">Wolkenstein P, Machovcová A, Szepietowski JC, et al. Acne prevalence and associations with lifestyle: a cross-sectional online survey of adolescents/young adults in 7 European countries. J Eur Acad Dermatol Venereol 2018; 32:298.</a></li><li><a class="nounderline abstract_t">Goulden V, Clark SM, Cunliffe WJ. Post-adolescent acne: a review of clinical features. Br J Dermatol 1997; 136:66.</a></li><li><a class="nounderline abstract_t">O'Neill AM, Gallo RL. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris. Microbiome 2018; 6:177.</a></li><li><a class="nounderline abstract_t">Imperato-McGinley J, Gautier T, Cai LQ, et al. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metab 1993; 76:524.</a></li><li><a class="nounderline abstract_t">Grice EA, Kong HH, Conlan S, et al. Topographical and temporal diversity of the human skin microbiome. Science 2009; 324:1190.</a></li><li><a class="nounderline abstract_t">Fitz-Gibbon S, Tomida S, Chiu BH, et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol 2013; 133:2152.</a></li><li><a class="nounderline abstract_t">Hall JB, Cong Z, Imamura-Kawasawa Y, et al. Isolation and Identification of the Follicular Microbiome: Implications for Acne Research. J Invest Dermatol 2018; 138:2033.</a></li><li><a class="nounderline abstract_t">Brüggemann H, Henne A, Hoster F, et al. The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 2004; 305:671.</a></li><li><a class="nounderline abstract_t">Brüggemann H. Insights in the pathogenic potential of Propionibacterium acnes from its complete genome. Semin Cutan Med Surg 2005; 24:67.</a></li><li><a class="nounderline abstract_t">Lomholt HB, Kilian M. Population genetic analysis of Propionibacterium acnes identifies a subpopulation and epidemic clones associated with acne. PLoS One 2010; 5:e12277.</a></li><li><a class="nounderline abstract_t">Agak GW, Qin M, Nobe J, et al. Propionibacterium acnes Induces an IL-17 Response in Acne Vulgaris that Is Regulated by Vitamin A and Vitamin D. J Invest Dermatol 2014; 134:366.</a></li><li><a class="nounderline abstract_t">Agak GW, Kao S, Ouyang K, et al. Phenotype and Antimicrobial Activity of Th17 Cells Induced by Propionibacterium acnes Strains Associated with Healthy and Acne Skin. J Invest Dermatol 2018; 138:316.</a></li><li><a class="nounderline abstract_t">Li ZJ, Choi DK, Sohn KC, et al. Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes. J Invest Dermatol 2014; 134:2747.</a></li><li><a class="nounderline abstract_t">Qin M, Pirouz A, Kim MH, et al. Propionibacterium acnes Induces IL-1β secretion via the NLRP3 inflammasome in human monocytes. J Invest Dermatol 2014; 134:381.</a></li><li><a class="nounderline abstract_t">Shibata M, Katsuyama M, Onodera T, et al. Glucocorticoids enhance Toll-like receptor 2 expression in human keratinocytes stimulated with Propionibacterium acnes or proinflammatory cytokines. J Invest Dermatol 2009; 129:375.</a></li><li><a class="nounderline abstract_t">Kim J, Ochoa MT, Krutzik SR, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002; 169:1535.</a></li><li><a class="nounderline abstract_t">Sugisaki H, Yamanaka K, Kakeda M, et al. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease. J Dermatol Sci 2009; 55:47.</a></li><li><a class="nounderline abstract_t">Jahns AC, Lundskog B, Ganceviciene R, et al. An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study. Br J Dermatol 2012; 167:50.</a></li><li><a class="nounderline abstract_t">Trivedi NR, Gilliland KL, Zhao W, et al. Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling. J Invest Dermatol 2006; 126:1071.</a></li><li><a class="nounderline abstract_t">Chronnell CM, Ghali LR, Ali RS, et al. Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. J Invest Dermatol 2001; 117:1120.</a></li><li><a class="nounderline abstract_t">Di Landro A, Cazzaniga S, Parazzini F, et al. Family history, body mass index, selected dietary factors, menstrual history, and risk of moderate to severe acne in adolescents and young adults. J Am Acad Dermatol 2012; 67:1129.</a></li><li><a class="nounderline abstract_t">Ballanger F, Baudry P, N'Guyen JM, et al. Heredity: a prognostic factor for acne. Dermatology 2006; 212:145.</a></li><li><a class="nounderline abstract_t">Xu SX, Wang HL, Fan X, et al. The familial risk of acne vulgaris in Chinese Hans - a case-control study. J Eur Acad Dermatol Venereol 2007; 21:602.</a></li><li><a class="nounderline abstract_t">Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol 1999; 141:297.</a></li><li><a class="nounderline abstract_t">Bataille V, Snieder H, MacGregor AJ, et al. The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women. J Invest Dermatol 2002; 119:1317.</a></li><li><a class="nounderline abstract_t">Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49:S1.</a></li><li><a class="nounderline abstract_t">Cordain L, Lindeberg S, Hurtado M, et al. Acne vulgaris: a disease of Western civilization. Arch Dermatol 2002; 138:1584.</a></li><li><a class="nounderline abstract_t">Thiboutot DM, Strauss JS. Diet and acne revisited. Arch Dermatol 2002; 138:1591.</a></li><li><a class="nounderline abstract_t">Bershad S. The unwelcome return of the acne diet. Arch Dermatol 2003; 139:940.</a></li><li><a class="nounderline abstract_t">Spencer EH, Ferdowsian HR, Barnard ND. Diet and acne: a review of the evidence. Int J Dermatol 2009; 48:339.</a></li><li><a class="nounderline abstract_t">Grossi E, Cazzaniga S, Crotti S, et al. The constellation of dietary factors in adolescent acne: a semantic connectivity map approach. J Eur Acad Dermatol Venereol 2016; 30:96.</a></li><li><a class="nounderline abstract_t">Adebamowo CA, Spiegelman D, Danby FW, et al. High school dietary dairy intake and teenage acne. J Am Acad Dermatol 2005; 52:207.</a></li><li><a class="nounderline abstract_t">Thiboutot D. Acne: hormonal concepts and therapy. Clin Dermatol 2004; 22:419.</a></li><li><a class="nounderline abstract_t">Cappel M, Mauger D, Thiboutot D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol 2005; 141:333.</a></li><li><a class="nounderline abstract_t">Holmes MD, Pollak MN, Willett WC, Hankinson SE. Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 2002; 11:852.</a></li><li><a class="nounderline abstract_t">Adebamowo CA, Spiegelman D, Berkey CS, et al. Milk consumption and acne in adolescent girls. Dermatol Online J 2006; 12:1.</a></li><li><a class="nounderline abstract_t">Adebamowo CA, Spiegelman D, Berkey CS, et al. Milk consumption and acne in teenaged boys. J Am Acad Dermatol 2008; 58:787.</a></li><li><a class="nounderline abstract_t">LaRosa CL, Quach KA, Koons K, et al. Consumption of dairy in teenagers with and without acne. J Am Acad Dermatol 2016; 75:318.</a></li><li><a class="nounderline abstract_t">Ulvestad M, Bjertness E, Dalgard F, Halvorsen JA. Acne and dairy products in adolescence: results from a Norwegian longitudinal study. J Eur Acad Dermatol Venereol 2017; 31:530.</a></li><li><a class="nounderline abstract_t">Smith RN, Mann NJ, Braue A, et al. The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol 2007; 57:247.</a></li><li><a class="nounderline abstract_t">Fabbrocini G, Izzo R, Faggiano A, et al. Low glycaemic diet and metformin therapy: a new approach in male subjects with acne resistant to common treatments. Clin Exp Dermatol 2016; 41:38.</a></li><li><a class="nounderline abstract_t">Bowe WP, Joshi SS, Shalita AR. Diet and acne. J Am Acad Dermatol 2010; 63:124.</a></li><li><a class="nounderline abstract_t">Rasmussen JE, Smith SB. Patient concepts and misconceptions about acne. Arch Dermatol 1983; 119:570.</a></li><li><a class="nounderline abstract_t">Green J, Sinclair RD. Perceptions of acne vulgaris in final year medical student written examination answers. Australas J Dermatol 2001; 42:98.</a></li><li><a class="nounderline abstract_t">Yosipovitch G, Tang M, Dawn AG, et al. Study of psychological stress, sebum production and acne vulgaris in adolescents. Acta Derm Venereol 2007; 87:135.</a></li><li><a class="nounderline abstract_t">Chiu A, Chon SY, Kimball AB. The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress. Arch Dermatol 2003; 139:897.</a></li><li><a class="nounderline abstract_t">Vora S, Ovhal A, Jerajani H, et al. Correlation of facial sebum to serum insulin-like growth factor-1 in patients with acne. Br J Dermatol 2008; 159:990.</a></li><li><a class="nounderline abstract_t">Aizawa H, Niimura M. Elevated serum insulin-like growth factor-1 (IGF-1) levels in women with postadolescent acne. J Dermatol 1995; 22:249.</a></li><li><a class="nounderline abstract_t">Nagpal M, De D, Handa S, et al. Insulin Resistance and Metabolic Syndrome in Young Men With Acne. JAMA Dermatol 2016; 152:399.</a></li><li><a class="nounderline abstract_t">Tsai MC, Chen W, Cheng YW, et al. Higher body mass index is a significant risk factor for acne formation in schoolchildren. Eur J Dermatol 2006; 16:251.</a></li><li><a class="nounderline abstract_t">Halvorsen JA, Vleugels RA, Bjertness E, Lien L. A population-based study of acne and body mass index in adolescents. Arch Dermatol 2012; 148:131.</a></li><li><a class="nounderline abstract_t">Galobardes B, Davey Smith G, Jeffreys M, et al. Acne in adolescence and cause-specific mortality: lower coronary heart disease but higher prostate cancer mortality: the Glasgow Alumni Cohort Study. Am J Epidemiol 2005; 161:1094.</a></li><li><a class="nounderline abstract_t">Snast I, Dalal A, Twig G, et al. Acne and obesity: A nationwide study of 600,404 adolescents. J Am Acad Dermatol 2019; 81:723.</a></li><li><a class="nounderline abstract_t">Lu PH, Hsu CH. Body mass index is negatively associated with acne lesion counts in Taiwanese women with post-adolescent acne. J Eur Acad Dermatol Venereol 2015; 29:2046.</a></li><li class="breakAll">Zaenglein AK, Thiboutot DM. Acne vulgaris. In: Dermatology, 2nd ed, Bolognia JL, Jorizzo JL, Rapini RP, et al (Eds), Elsevier, 2008. p.495.</li><li><a class="nounderline abstract_t">Lucky AW. Quantitative documentation of a premenstrual flare of facial acne in adult women. Arch Dermatol 2004; 140:423.</a></li><li><a class="nounderline abstract_t">Stoll S, Shalita AR, Webster GF, et al. The effect of the menstrual cycle on acne. J Am Acad Dermatol 2001; 45:957.</a></li><li><a class="nounderline abstract_t">Pochi PE, Shalita AR, Strauss JS, et al. Report of the Consensus Conference on Acne Classification. Washington, D.C., March 24 and 25, 1990. J Am Acad Dermatol 1991; 24:495.</a></li><li><a class="nounderline abstract_t">Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol 1997; 137:246.</a></li><li><a class="nounderline abstract_t">Dalgard F, Gieler U, Holm JØ, et al. Self-esteem and body satisfaction among late adolescents with acne: results from a population survey. J Am Acad Dermatol 2008; 59:746.</a></li><li><a class="nounderline abstract_t">Greywal T, Zaenglein AL, Baldwin HE, et al. Evidence-based recommendations for the management of acne fulminans and its variants. J Am Acad Dermatol 2017; 77:109.</a></li><li class="breakAll">Zaenglein AK, Graber EM, Thiboutot DM, et al. Acne vulgaris and acneiform eruptions. In: Dermatology in General Medicine, 7th ed, Wolff K, Goldsmith LA, Katz SI, et al (Eds), McGraw Hill, 2008. p.690.</li><li><a class="nounderline abstract_t">Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74:945.</a></li><li><a class="nounderline abstract_t">Eichenfield LF, Krakowski AC, Piggott C, et al. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics 2013; 131 Suppl 3:S163.</a></li><li><a class="nounderline abstract_t">Friedlander SF, Baldwin HE, Mancini AJ, et al. The acne continuum: an age-based approach to therapy. Semin Cutan Med Surg 2011; 30:S6.</a></li></ol></div><div id="topicVersionRevision">Topic 39 Version 33.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9293656" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Descriptive epidemiology of acne vulgaris in the community.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17945383" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The prevalence of acne in adults 20 years and older.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28707712" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Acne prevalence and associations with lifestyle: a cross-sectional online survey of adolescents/young adults in 7 European countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9039297" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Post-adolescent acne: a review of clinical features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30285861" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8381804" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19478181" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Topographical and temporal diversity of the human skin microbiome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23337890" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Propionibacterium acnes strain populations in the human skin microbiome associated with acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29548797" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Isolation and Identification of the Follicular Microbiome: Implications for Acne Research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15286373" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The complete genome sequence of Propionibacterium acnes, a commensal of human skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16092793" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Insights in the pathogenic potential of Propionibacterium acnes from its complete genome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20808860" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Population genetic analysis of Propionibacterium acnes identifies a subpopulation and epidemic clones associated with acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23924903" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Propionibacterium acnes Induces an IL-17 Response in Acne Vulgaris that Is Regulated by Vitamin A and Vitamin D.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28864077" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Phenotype and Antimicrobial Activity of Th17 Cells Induced by Propionibacterium acnes Strains Associated with Healthy and Acne Skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24820890" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23884315" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Propionibacterium acnes Induces IL-1βsecretion via the NLRP3 inflammasome in human monocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18704103" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Glucocorticoids enhance Toll-like receptor 2 expression in human keratinocytes stimulated with Propionibacterium acnes or proinflammatory cytokines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12133981" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19375895" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22356121" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16528362" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11710922" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22386050" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Family history, body mass index, selected dietary factors, menstrual history, and risk of moderate to severe acne in adolescents and young adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16484821" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Heredity: a prognostic factor for acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17447973" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The familial risk of acne vulgaris in Chinese Hans - a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10468803" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12485434" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12833004" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Management of acne: a report from a Global Alliance to Improve Outcomes in Acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12472346" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Acne vulgaris: a disease of Western civilization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12472347" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Diet and acne revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12873898" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The unwelcome return of the acne diet.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19335417" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Diet and acne: a review of the evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25438834" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The constellation of dietary factors in adolescent acne: a semantic connectivity map approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15692464" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : High school dietary dairy intake and teenage acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15556729" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Acne: hormonal concepts and therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15781674" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12223429" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17083856" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Milk consumption and acne in adolescent girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18194824" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Milk consumption and acne in teenaged boys.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27241803" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Consumption of dairy in teenagers with and without acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27422392" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Acne and dairy products in adolescence: results from a Norwegian longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17448569" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26053680" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Low glycaemic diet and metformin therapy: a new approach in male subjects with acne resistant to common treatments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20338665" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Diet and acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6222703" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Patient concepts and misconceptions about acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11309030" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Perceptions of acne vulgaris in final year medical student written examination answers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17340019" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Study of psychological stress, sebum production and acne vulgaris in adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12873885" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18652583" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Correlation of facial sebum to serum insulin-like growth factor-1 in patients with acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7608381" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Elevated serum insulin-like growth factor-1 (IGF-1) levels in women with postadolescent acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26720707" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Insulin Resistance and Metabolic Syndrome in Young Men With Acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16709487" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Higher body mass index is a significant risk factor for acne formation in schoolchildren.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22250253" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : A population-based study of acne and body mass index in adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15937017" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Acne in adolescence and cause-specific mortality: lower coronary heart disease but higher prostate cancer mortality: the Glasgow Alumni Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30978426" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Acne and obesity: A nationwide study of 600,404 adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25266447" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Body mass index is negatively associated with acne lesion counts in Taiwanese women with post-adolescent acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25266447" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Body mass index is negatively associated with acne lesion counts in Taiwanese women with post-adolescent acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15096370" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Quantitative documentation of a premenstrual flare of facial acne in adult women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11712049" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The effect of the menstrual cycle on acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1829466" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Report of the Consensus Conference on Acne Classification. Washington, D.C., March 24 and 25, 1990.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9292074" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Suicide in dermatological patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19119094" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Self-esteem and body satisfaction among late adolescents with acne: results from a population survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28619551" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Evidence-based recommendations for the management of acne fulminans and its variants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28619551" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Evidence-based recommendations for the management of acne fulminans and its variants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26897386" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Guidelines of care for the management of acne vulgaris.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23637225" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Evidence-based recommendations for the diagnosis and treatment of pediatric acne.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21943566" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : The acne continuum: an age-based approach to therapy.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
